DHTKD1 and neoplasm: In the present study, we constructed a novel dual specific anti-tumor oncolytic adenovirus Ad-hTERT-E1a-HN by inserting NDV HN gene and hTERT promoter into a RAPAd.I adenovirus vector, as well as the control recombinant adenoviruses (Figure 1A).